Stanley M. Marks, M.D. is a co-founder of CTSI and a leading visionary behind bringing quality cancer care to developing markets. Dr. Marks is currently the Chairman, Director of Clinical Services and Chief Medical Officer for UPMC CancerCenter. He also serves as Chief, Division of Hematology/Oncology, UPMC Shadyside Hospital and clinical professor of medicine for the University of Pittsburgh School of Medicine, as well as Medical Director of Forbes Hospice. Dr. Marks founded Oncology Hematology Association (OHA) in 1978, and, under his leadership, OHA grew to become one of the largest hematology-oncology practices in Pennsylvania with 30 physicians practicing in 21 locations. In 2000, OHA merged with University of Pittsburgh Cancer Institute (UPCI) to create one of the largest cancer care networks in the U.S.
Dr. Marks was educated at the University of Pittsburgh, receiving his bachelor’s degree in biology in 1969, followed by a medical degree in 1973. Following an internship and residency at UPMC Presbyterian, he served a hematology-oncology fellowship at the Peter Bent Brigham Hospital and Harvard Medical School, as well as the Dana Farber Cancer Center.
Dr. Marks has served as President of The Leukemia & Lymphoma Society and President of the Allegheny County Medical Society. In addition, he has served on the board of directors of the American Cancer Society, Allegheny County Medical Society, Pittsburgh Research Institute, UPMC Cancer Centers, Pittsburgh Pain Society, Burger King Cancer Caring Center, and Juvenile Diabetes Research Foundation. Dr. Marks is also on the Corporate Board of Highmark Blue Cross/Blue Shield, serves on the Credential Committee of Highmark, and as a Professional Consultant in Hematology/Oncology for Medicare. He is also a founder of the local Juvenile Diabetes Foundation chapter.
Dr. Marks has authored numerous publications and is the recipient of several awards, including the National Research Service Award from the United States Public Health Service, Golden Apple for Excellence in Teaching, Pittsburgh Business Times Health Care Hero Award, and for the past several years has been named on the list of Best Doctors in America.
Over the past two decades, Dr. Marks has established strong professional, personal and social relationships within the community. He is truly beloved by his patients and is consistently named one of the Pittsburgh’s Top Doctors by the Pittsburgh Business Times, Pittsburgh Magazine and recently Channel 11 (WPXI). He has profoundly affected the lives of thousands of patients and their families as they find themselves coping with Cancer. He remains passionately committed to advancing the level of cancer care in our community.
Joseph A. Nicholas, President and CEO of CTSI, began his career at Eastman Kodak, holding prominent positions in sales, marketing and product development. During the mid 90s, Mr. Nicholas was recruited to assist in starting a technology venture, Allin Interactive, where he played an integral role in raising public money in the successful pursuit of an IPO with parent company, Allin. Mr. Nicholas transitioned from Allin to Marconi plc, overseeing efforts to develop integrated solutions for the hospital market, including the concept of shared PACS to centralize data and reduce costs for healthcare facilities. In 2001, Mr. Nicholas was named CEO/President of a UPMC venture company, D3 Radiation Planning.
UPMC is a multi-billion dollar entity, non-profit provider of services in Western Pennsylvania. D3 offers advanced radiation treatment planning for therapies such as Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT) to hospitals and freestanding institutions on an international scale. D3 pioneered a model that centralized key processes and allowed community hospitals and private radiation practices to deploy leading edge technologies in their marketplaces.
In early 2005, Mr. Nicholas became CEO of Alliance Oncology, a joint venture between D3, UPMC and Alliance Imaging. Under his leadership, Alliance Oncology opened two cancer centers in partnership with Providence Hospital of Southern California. At Alliance, Mr. Nicholas also negotiated partnerships with two world renowned organizations in Boston, Massachusetts.
Mr. Nicholas left Alliance Oncology in early 2006 to lead the efforts of CTSI. He graduated from Indiana University, where he received the prestigious Eastman Kodak Scholarship Award.
Andrew J. Shogan has operated in various management roles since CTSI’s inception in 2006. He is currently Chief Operating Officer and also serves on the Company’s Board of Directors.
Mr. Shogan began his career with Deutsche Bank Securities where he held positions of increasing responsibility in the Health Care Investment Banking Group. His primary responsibilities included managing day-to-day tasks on financing and merger and acquisition projects as well as contributing to a range of other corporate finance activities on behalf of clients. While at Deutsche Bank, Mr. Shogan worked with biotechnology, specialty pharmaceutical, drug delivery, medical device, life sciences and health care services companies on a wide variety of transactions.
Mr. Shogan graduated from Middlebury College with a Bachelor of Arts degree in both Economics and Psychology and received a Master of Business Administration with a major in Finance from The Wharton School of the University of Pennsylvania.
Peter G. Ellis, M.D., is currently Director, Medical Oncology Network of UPMC Cancer Centers, one of the largest cancer centers in the USA serving over 36,000 patients annually. In his capacity as Medical Oncology Director, Dr. Ellis manages 80 medical oncologists and leads the UPMC Cancer Centers efforts in the task of medical protocol development and standardization of treatment. His initiatives led to the Clinical Pathways program, which was developed through disease specific, multidisciplinary committees, resulting in best practice standards for all common malignancies. UPMC Cancer Centers has received national acclaim for this program.From 1997 until he left US Oncology in 2004, Dr. Ellis served as the National Chairman of the Pharmacy and Therapeutics Committee for US Oncology, the largest integrated oncology network in the country, providing an estimated 15% of all cancer care nationwide. As Chairman, he led efforts to unify physicians around the network to achieve common goals in the interest of patient care and fiscal responsibility. This was achieved primarily through initiatives to standardize aspects of patient care delivery throughout the country.
Dr. Ellis earned his B.A. at the University of Virginia and completed his M.D. at the University of Pittsburgh School of Medicine. He performed his internal medicine training at the Hospital of the University of Pennsylvania and his fellowship in Hematology and Oncology at Duke University.
Dr. Ellis is an Associate Clinical Professor of Medicine at the University of Pittsburgh School of Medicine. He serves as the Director of Oncology at UPMC St. Margaret Hospital. He is chair of the St. Margaret Foundation and treasurer of the local private school board. Dr. Ellis is a member of the ASCO National Clinical Practice Committee. Dr. Ellis has numerous publications, board representations and charitable involvements.
Jason Henne joined CTSI as Controller in August 2010. Most recently, Mr. Henne served as Director, Finance & Accounting at Philips Respironics. Mr. Henne was responsible for a wide range of finance and accounting functions. In addition to his normal day-to-day activities, Mr. Henne was an integral member of the finance integration team to integrate Respironics into Philips Healthcare after Respironics was acquired in 2008. Mr. Henne began his career with the global accounting firm, Ernst & Young, serving clients in diverse industries in the Pittsburgh and Los Angeles markets. While at Ernst & Young, Mr. Henne supported his clients in the areas of external audit, internal audit, and acquisition support. Mr. Henne departed Ernst & Young to join one of his clients, The Walt Disney Company in 2003. While at Disney, Mr. Henne held multiple positions of increasing responsibility within finance and accounting, including his final position before relocating back to the Pittsburgh area, Director of Accounting for Walt Disney Home Entertainment.Mr. Henne graduated from Duquesne University with a Bachelor of Science degree in Accounting.
Mr. Rajesh V. Manthena joined CTSI in April 2011 as Director of International Development. Mr. Manthena has over 11 years of experience in supply chain management in the manufacturing and financial industries. Most recently, Mr. Manthena was responsible for leading an ERP implementation at Bloomberg Financial. In some of his previous positions, Mr. Manthena served in a wide range of key roles in planning, project management, implementation and business analysis in large scale corporations like Philips, American Standard and Bloomberg Financial. Mr. Manthena was born and brought up in India before moving to the U.S. for his higher education and work experience in the late 90’s. He earned a Master of Science degree in Information Sciences from New Jersey Institute of Technology and a Bachelor of Science in Mechanical Engineering from Amravati University, India.
Dr. V. Krishna Komanduri is currently Director of Physics at CTSI for the Company’s domestic and international operations. He has been associated with CTSI since its inception and helped as an advisor in all technical matters related to the construction of accelerator-housing bunkers, equipment specification, recruitment of physics staff and quality assurance. Before joining CTSI, Dr. Komanduri held various senior positions in the radiation oncology field including senior physicist for D3 Radiation Planning, Chief of Clinical Physics at UPMC, Shadyside as well as Chief of Clinical Physics at University of Kentucky. He has been very active in teaching Radiation Oncology residents as well as in the AAPM accredited Medical Physics program in the U.S.
Dr. Komanduri has extensive research experience both in medical physics as well as in experimental physics and has over 50 publications and a patent to his credit. His current interests include adopting new technologies for cancer treatment on a clinical level as well as the electronic integration of clinics for unified quality assurance and quality management.
Dr. Komanduri has a Ph.D. in physics from University of Delhi, trained in Britain in medical physics and is board certified by American Board of Radiology for practicing medical physics. He is registered and holds licenses for practicing Therapeutic Radiology in several states in the U.S.